Zydus Lifesciences Q3 Results

  • BSE: 532321
  • NSE: ZYDUSLIFE
  • ISIN: INE010B01027
  • Sector: Biotechnology & Drugs
BSE
962.714.00 (1.48%)
Volume16.80 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
964.3515.30 (1.61%)
Volume2.66 M
Updated: Mon 25 Nov, 2024 | 15:44:11
Today: 946.35
967.00
52-Wk: 628.05
1,323.90

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Zydus Lifesciences Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 4,505.204,368.80-%4,362.30-%
    Selling/ General/ Admin Expenses Total 817.30752.90-%689.00-%
    Depreciation/ Amortization 194.80184.20-%181.60-%
    Other Operating Expenses Total 1,137.601,078.20-%1,206.90-%
    Total Operating Expense 3,618.203,489.10-%3,587.90-%
    Operating Income 887.00879.70-%774.40-%
    Net Income Before Taxes 925.501,007.20-%780.10-%
    Net Income 789.60800.70-%622.90-%
    Diluted Normalized EPS 7.587.92-%6.15-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts